Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

By Benzi G.   Moretti A.  

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

By Zemek Filip   Drtinova Lucie   Nepovimova Eugenie   Sepsova Vendula   Korabecny Jan   Klimes Jiri   Kuca Kamil  

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 759-774

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase Inhibitors and Sleep Architecture in Patients with Alzheimer's Disease

By Cooke Jana R.   Loredo Jose S.   Liu Lianqi   Marler Matthew   Corey-Bloom Jody   Fiorentino Lavinia   Harrison Tamara   Ancoli-Israel Sonia  

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 503-511

Adis International

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease

By Recanatini Maurizio   Cavalli Andrea  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1853-1865

Informa Healthcare

Access to resources Recommend Favorite